Data compiled by Redley Lamar · ChainSifter Intelligence
4Suppliers
4Customers
2Debt Items
4Related Chains
Source-Backed Evidence Depth
BGM Group Ltd. (BGM) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
11Total relationships
2Distinct source URLs
7High confidence
0.794Average confidence
2026-10-28Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
BGM Group Ltd. Suppliers
Ticker
Name
Confidence
Evidence
SUPPLIERS
SUPPLIERS
90%
For the fiscal year ended September 30, 2024, two of the suppliers of the WFOE and the VIE and its subsidiaries accounted for 12% and 10% of the total purchases.
Reciprocal relationship from MAAS graph: Reciprocal relationship from BGM graph: Reciprocal relationship from MAAS graph: r giving effect to the reverse share split effected on June 23, 2025) to the …
VENDOR
VENDOR
80%
For the fiscal year ended September 30, 2022, one vendor accounted for 14% of total purchase.
Reciprocal relationship from AIFU graph: Reciprocal relationship from BGM graph: Reciprocal relationship from AIFU graph: Reciprocal relationship from BGM graph: Reciprocal relationship from AIFU gra…
BGM Group Ltd. Customers
Ticker
Name
Confidence
Evidence
CUSTOMERS
CUSTOMERS
90%
For the fiscal year ended September 30, 2022, two customers represented approximately 11% and 11% of the sales of the WFOE and the VIE and its subsidiaries, respectively.
HOLDER-ADDRESS-LEGAL-USE-METERS-GANSU-QILIANSHAN
HOLDER-ADDRESS-LEGAL-USE-METERS-GANSU-QILIANSHAN
62%
n technology and manufacturing facilities, Gansu QLS’s production capacity of oxytetracycline has reached its industrial upper limit. After thorough research and investigation, the R&D department of …
USE-GANSU-QILIANSHAN-PHARMACEUTICAL-CO-LTD
USE-GANSU-QILIANSHAN-PHARMACEUTICAL-CO-LTD
62%
n technology and manufacturing facilities, Gansu QLS’s production capacity of oxytetracycline has reached its industrial upper limit. After thorough research and investigation, the R&D department of …
ZH-CPA-LLC
ZH-CPA-LLC
62%
ents For the Year ended September 30, 2023 The VIE and Consolidated Parent Qilian HK WFOE subsidiaries Eliminat…
BGM Group Ltd. Debt Obligations
Instrument
Description
Confidence
Evidence
BGM-DEBT
Debt stack $1.8M
90%
Market cache reports total debt of $1.8M.
BGM-DEBT-8173
Warrants outstanding: 5.5
90%
xbrl warrant detail from xbrl 2024-04-19.
BGM Group Ltd. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for BGM Group Ltd..
BGM Group Ltd. Ownership
Holder
Name
Confidence
Evidence
BGM-OWNER-HRT-FINANCIAL-LP
HRT FINANCIAL LP
90%
13F overlay lists HRT FINANCIAL LP as top holder; 14 tracked holders.
